Chitosan is a fiber-like substance from shellfish or fungi that binds fat and bile in the gut so they pass out of the body. Human evidence is consistent but small: slight drops in body weight, body fat, and total cholesterol, plus some blood-sugar improvement. Best viewed as a minor, low-cost add-on to diet and exercise. (Full Review)

Protocol

Dose

2.4–3 g/day

Divided across meals; the dose range at which effects were most consistent

Timing

With or before meals

Especially the largest fat-containing meals; not on an empty stomach

Titration

Start ~1 g/day

Increase gradually toward 2.4–3 g as tolerated to limit GI side effects

Time to effect

Weight & Body Fat

8–12 weeks+

Gradual and modest; sustained use needed to become measurable

Cholesterol

≥12–13 weeks

Most apparent with sustained daily use

Blood Sugar

≥12–13 weeks

Glucose benefits in trials generally needed at least 13 weeks

Benefits

Medium: Modest reduction in body weight and body fat; reduction in total cholesterol

Low: Improved fasting blood sugar and long-term glucose control; modest blood pressure reduction

Speculative: Antioxidant and gut-microbiome effects; wound healing and antimicrobial applications

Contraindications

Shellfish allergy (unless verified fungal source)

Pregnancy or breastfeeding

Severe chronic constipation

Significant fat-soluble vitamin deficiency

Key Interactions

Prescription drugs (warfarin, narrow-therapeutic-index drugs)

Over-the-counter orlistat (Alli, Xenical)

Fat-soluble vitamin supplements (A, D, E, K), fish-oil

Binding/viscous fibers (psyllium, glucomannan, beta-glucan), lipid-lowering supplements (plant sterols, red yeast rice)

Risk & Side Effects

High: Gastrointestinal disturbances

Medium: Shellfish allergy reactions; reduced absorption of fat-soluble vitamins and nutrients

Low: Drug binding and reduced medication absorption

Speculative: Effects on the gut microbiome and long-term use

Monitoring

Marker	Target	Why
Total Cholesterol	< 180 mg/dL	Chitosan's most consistent lipid effect is on total cholesterol
LDL Cholesterol	< 80 mg/dL	Key cardiovascular driver; chitosan's effect on it is weak
Fasting Glucose	70–85 mg/dL	Chitosan may modestly lower fasting glucose in metabolic syndrome
Hemoglobin A1c	< 5.4%	Reflects average blood sugar over 2–3 months; a chitosan glucose benefit
Body Weight / Body-Fat %	Body fat ~10–20% (men), ~18–28% (women)	Primary outcome chitosan is used for
Vitamin D (25-OH)	40–60 ng/mL	Chitosan may reduce fat-soluble vitamin absorption with chronic use
Blood Pressure	< 120/80 mm Hg	Chitosan associated with small blood-pressure reductions

Cadence: Baseline, then around 12 weeks, and thereafter every 6–12 months if use continues; watch fat-soluble vitamin status during prolonged use.

Qualitative Assessment

Digestive tolerance (absence of troublesome constipation, bloating, or discomfort)
Energy levels and sense of satiety around meals
Adherence and convenience of fitting dosing around meals
Overall progress toward weight or metabolic goals when combined with diet and exercise

Chitosan for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment